Brief: Akari Therapeutics Announces $12.75 Million Registered Direct Offering

Akari Therapeutics

12/09/2022 13:38

Sept 12 (Reuters) - Akari Therapeutics PLC  AKTX.O :
    * AKARI THERAPEUTICS ANNOUNCES $12.75 MILLION REGISTERED
DIRECT
OFFERING
    * AKARI THERAPEUTICS - ENTERED INTO DEFINITIVE AGREEMENTS
FOR
PURCHASE AND SALE OF 15 MILLION AKARI ADSS AT A PURCHASE PRICE
OF $0.85 PER ADS

Source text for Eikon:  ID:nGNX5Cx47C 
Further company coverage:  AKTX.O 

 ((reuters.briefs@thomsonreuters.com;))